Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000320625 | SCV000330274 | pathogenic | not provided | 2019-05-30 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); Has not been previously published as pathogenic or benign to our knowledge |
Invitae | RCV000673370 | SCV002243176 | pathogenic | Cohen syndrome | 2023-06-04 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 280368). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. This sequence change creates a premature translational stop signal (p.Leu1918Argfs*12) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). |
Counsyl | RCV000673370 | SCV000798566 | likely pathogenic | Cohen syndrome | 2018-03-14 | no assertion criteria provided | clinical testing |